Chávez-Negrete A, Márquez-Celedonio FG, Soler-Huerta E, Rojas-Carrera SI, González-Santes M, Blanco-Cornejo AV, Rojas-Uribe M, Texon-Fernández O

Language: Spanish
References: 25
Page: 276-283
PDF size: 200.18 Kb.

ABSTRACT

Background: prehypertension is the category established in JNC-7, which designates the individuals that present diastolic blood pressure of 80-89 mm Hg and systolic blood pressure of 120-139 mm Hg, and it is associated to high rates of cardiovascular disease. The purpose of the study was to identify prevalence rates and their correlation with sociodemographic factors and comorbidity in a sample of a population of Veracruz, Mexico.
Methods: a cross-sectional and representative survey was chosen by means of probability sampling. Sociodemographic factors, lifestyle and anthropometric characteristics were assessed. Odds ratios and 95 % confi dence intervals were obtained.
Results: the prehypertension prevalence found was 33.8 %, with an average age of 40.9 ± 14.2 years in prehypertensive subjects, and 50.6 ± 12.7 in hypertension subjects (p ‹ 0.05). In relation with prehypertension, males presented a 1.48 (1.18-1.86) OR. Also, those who had more than 40 years had an OR of 1.9 (1.51-2.38); the ones with basic schooling, an OR of 1.73 (1.38-2.17); subjects with hyperglucemia, OR 3.0 (1.5-3.75); with overweight, OR 1.41 (1.01-1.68); and those with other comorbidities an OR of 1.61 (1.09-2.36).
Conclusions: a high prevalence of prehypertension was found in the sample, and it was associated to male gender subjects, aged above 40 years, with basic schooling and relevant comorbidities, such as diabetes and cardiovascular disease.

REFERENCES

1. Kearny P, Whelton M, Reynolds K, Muntner P, Whelton P, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.

2. Barquera S, Campos-Nonato I, Hernández-Barrera L, Villalpando S, Rodríguez-Gilabert C, Durazo-Arvizu R, et al. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex. 2010;52(Suppl 1):S63-S71.

3. Rojas-Martínez R, Aguilar-Salinas CA, Jiménez- Corona A, Gómez-Pérez FJ, Barquera S, Lazcano- Ponce E. Prevalence of obesity and metabolic syndrome components in Mexican adults without type 2 diabetes or hypertension. Salud Publica Mex. 2012;54(1):7-12. Texto libre en http://www.scielosp. org/scielo.php?script=sci_arttext&pid=S0036-3634 2012000100002&lng=en&nrm=iso&tlng=en

4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003; 289(19):2560-72.

5. Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke. 2005;36:1859- 63. Texto libre en http://stroke.ahajournals.org/ content/36/9/1859.long

6. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-Based Sample, the Strong Heart Study. Hypertension. 2006;47(3): 410-14.

7. Guo X, Zheng L, Zhang X, Zou L, Li J, Sun Z, et al. The Prevalence and heterogeneity of prehypertension: a meta-analysis and meta-regression of published literature worldwide. Cardiovasc J Africa. 2012;23(1):44-50. Texto libre en http://blues.sabinet. co.za/WebZ/Authorize?sessionid=0:autho=pubmed :password=pubmed2004&/AdvancedQuery?&form at=F&next=images/ejour/cardio1/cardio1_v23_n1_ a11.pdf

8. Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults; Trabzon Hypertension Study. J Public Health (Oxf). 2009;31(1):47-58. Texto libre en http://jpubhealth. oxfordjournals.org/content/31/1/47.long

9. Glasser SP, Judd S, Basile J, Lackland D, Halanych J, Cushman M, et al. Prehypertension, racial prevalence and its association with risk factors: analysis of the reasons for geographic and racial differences in stroke (REGARDS) Study. Am J Hypertens. 2011;24(2):194-99.

10. Tsai PS, Ke TL, Huang CJ, Tsai JC, Chen PL, Wang SY. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens. 2005;23(7):1355-60.

11. Meng XJ, Dong GH, Wang D, Liu MM, Liu YQ, Zhao Y, et al. Epidemiology of prehypertension and associated risk factors in urban adults from 33 communities in China-the CHPSNE Study. Circ J. 2012;76(4):900-06.

12. Vega-Alonso AT, Lozano-Alonso JE, Álamo-Sanz R, Llera-Muñoz C, et al. Prevalencia de la hipertensión arterial en la población de Castilla y León. Gac Sanit. 2008;22(4);330-36.

13. Jang SY, Ju EY, Choi S, Seo S, Kim DE, Park SW. Prehypertension and obesity in middle-aged Korean men and women: the third Korea national health and nutrition examinations survey (KNHANES III) study. J Public Health (Oxf). 34(4):562-69.

14. Ferguson TS, Tulloch-Reid MK, Younger NO, Mc- Farlane SR, Francis DK, Wilks RJ. Prehypertension in Jamaica: a review of data from recent studies. West Indian Med J. 2011;60(4): 429-33.

15. Nery AB, Mesquita ET, Lugon JR, Kang HC, de Miranda VA, de Souza BG et al. Prehypertension and cardiovascular risk factors in adults enrolled in a primary care programme. Eur J Cardiovasc Prev Rehabil. 2011;18(2):233-39.

16. Fong-Mata ER, Medina-Pérez C. Prevalencia de prehipertensión e hipertensión arterial en personal de enfermería. Med Int Mex. 2007;23(4):277-79. Texto libre en http://www.nietoeditores.com.mx/ volumen-23-num4-julio-agosto-2007/843-prevalencia- de-prehipertension-e-hipertension-arterial-enpersonal- de-enfermeria-.html

17. Jiménez-Corona A, López-Ridaura R, Stern MP, González-Villalpando C. Risk of progression to hypertension in a low-income Mexican population with pre-hypertension and normal blood pressure. Am J Hypertens. 2007;20(9):929-36. Texto libre en http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC2081156/

18. Guo X, Zou L, Zhang X, Li J, Zheng L, Sun Z. Prehypertension, A meta-analysis of the epidemiology, risk factors, and predictors of progression. Tex Heart Inst J. 2011;38(6):643-52.

19. Márquez-Celedonio FG, Texon-Fernández O, Chávez-Negrete A, Hernández-López S, Marín- Rendón S, Berlín-Lascurain S. Efi cacia clínica de la modifi cación del estilo de vida en el riesgo cardiovascular en prehipertensos: estudio PREHIPER I. Rev Esp Cardiol. 2009;62(1):86- 90. Texto libre en http://www.revespcardiol. org/es/efi cacia-clinica-modifi cacion-del-estilo/ articulo/13131364/

20. Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, et al. Serum albumin, Creactive protein, interleukin 6, and fetuin-A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006;47(1):139-48.

21. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288(16):2015-22. Texto libre en http://jama.jamanetwork.com/article. aspx?articleid=195433

22. Masuo K, Mikami H, Itoh M, Ogihara T, Tuck ML. Sympathetic activity and body mass index contribute to blood pressure levels. Hypertens Res. 2000;23(4):303-10.

23. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Co-expression of renin-angiotensin system genes in human adipose tissue. J. Hypertens. 1999;17:555-60.

24. Agyemang C, van Valkengoed I, van den Born BJ, Stronks K. Prevalence and determinants of prehypertension among African Surinamese, Hindustani Surinamese, and White Dutch ub Amsterdam, the Netherlands: the SUNSET study. Eur J Cardiovasc Prev Rehabil. 2007;14(6):775-81. Texto libre en http://cpr.sagepub.com/content/14/6/775.long

25. Greenlund KJ, Daviglux ML, Croft JB. Differences in healthy lifestyle characteristics between adults with prehypertension and normal blood pressure. J Hypertens. 2009;27(5):955-62.